Status:
COMPLETED
Multimodal Monitoring of Hemodynamics in Extremely Low Birth Weight Preterm Infant in a Canadian Tertiary Level Unit
Lead Sponsor:
University of Alberta
Conditions:
Hemodynamic Instability
Eligibility:
All Genders
23-28 years
Phase:
NA
Brief Summary
Low blood pressure is a common problem in the premature newborn and can affect over 30% of all Extremely Low Gestational Age Neonates (ELGAN) babies delivered less than 28 weeks completed. Neonatal cl...
Detailed Description
Background: Neonatal transition from the intra-uterine to extra-uterine environment is a complex, multi-organ process. The heart of a term neonate is anatomically and functionally mature to make the ...
Eligibility Criteria
Inclusion
- Preterm babies less than 29 weeks (ELGAN)
- Babies born in Royal Alexandra Hospital(RAH) and admitted to RAH-NICU for first 7days of life
Exclusion
- Structural heart diseases
- Major congenital disorder or chromosomal disorder
Key Trial Info
Start Date :
February 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2022
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT03841929
Start Date
February 15 2019
End Date
March 30 2022
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Alexandra Hospital-NICU
Edmonton, Alberta, Canada